NCT06823375 2026-03-04SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein ThrombosisChinese University of Hong KongPhase 2 Recruiting40 enrolled
NCT06844357 2025-04-06A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.Zhejiang Raygene Pharmaceuticals Co., LtdPhase 2/3 Recruiting300 enrolled